OBJECTIVE: Because of concern over the higher rates of failed abortion, many clinicians defer surgical abortion until 7 menstrual weeks or later. We conducted this study to evaluate the efficacy and safety of early surgical abortions that are performed by numerous physicians in a community-based setting. STUDY DESIGN: We prospectively gathered data on all eligible patients who had surgical abortions at <6 weeks of gestation at 3 Planned Parenthood clinics from January 1, 1998, to August 31, 2000. Outcomes were evaluated with the use of proportions with 95% CI and chi(2) analysis. RESULTS: A total of 1132 women had early surgical abortions during the study interval, and follow-up was available for 750 of those women (66%). Seventeen women (2.3%; 95% CI, 1.4%, 3.7%) had failed attempted abortions. Other complications occurred in 13 women. CONCLUSION: Early surgical abortion is safe and effective. In this series, the frequency of complications that required curettage was similar to that reported with mifepristone and vaginal misoprostol.
OBJECTIVE: Because of concern over the higher rates of failed abortion, many clinicians defer surgical abortion until 7 menstrual weeks or later. We conducted this study to evaluate the efficacy and safety of early surgical abortions that are performed by numerous physicians in a community-based setting. STUDY DESIGN: We prospectively gathered data on all eligible patients who had surgical abortions at <6 weeks of gestation at 3 Planned Parenthood clinics from January 1, 1998, to August 31, 2000. Outcomes were evaluated with the use of proportions with 95% CI and chi(2) analysis. RESULTS: A total of 1132 women had early surgical abortions during the study interval, and follow-up was available for 750 of those women (66%). Seventeen women (2.3%; 95% CI, 1.4%, 3.7%) had failed attempted abortions. Other complications occurred in 13 women. CONCLUSION: Early surgical abortion is safe and effective. In this series, the frequency of complications that required curettage was similar to that reported with mifepristone and vaginal misoprostol.
Authors: Tracy A Weitz; Diana Taylor; Sheila Desai; Ushma D Upadhyay; Jeff Waldman; Molly F Battistelli; Eleanor A Drey Journal: Am J Public Health Date: 2013-01-17 Impact factor: 9.308
Authors: Ian M Bennett; Margaret Baylson; Karin Kalkstein; Ginger Gillespie; Scarlett L Bellamy; Joan Fleischman Journal: Ann Fam Med Date: 2009 Nov-Dec Impact factor: 5.166
Authors: Katherine Kortsmit; Tara C Jatlaoui; Michele G Mandel; Jennifer A Reeves; Titilope Oduyebo; Emily Petersen; Maura K Whiteman Journal: MMWR Surveill Summ Date: 2020-11-27
Authors: Katherine Kortsmit; Michele G Mandel; Jennifer A Reeves; Elizabeth Clark; H Pamela Pagano; Antoinette Nguyen; Emily E Petersen; Maura K Whiteman Journal: MMWR Surveill Summ Date: 2021-11-26